Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
For maintenance in chronic conditions, monthly injections are typical
This should only be used if the patient has been confirmed to have had inadequate responses to other forms of treatment
Ready-to-Use Research Formulation Supplied as a liquid preparation with no reconstitution required
Evidence snapshot: The strongest human evidence comes from a 2-year randomized controlled trial in 65 healthy older adults (Nass et al., 2008, Annals of Internal Medicine) showing sustained GH/IGF-1 increases and preserved fat-free mass, plus an earlier short-term human polysomnography study on sleep (Copinschi et al., 1997, Neuroendocrinology, PMID 9349662)
AOD-9604 produces no IGF-1 elevation, potentially making it more appropriate for individuals with cancer history or elevated baseline cancer risk
Results vary depending on the cause and extent of hair loss, but many users report noticeable improvements in hair density and thickness within 3-6 months of consistent use
US$ 27.02
US$ 29.30
US$ 20.91
US$ 21.05
US$ 25.24
US$ 28.91
